Clinical trial
A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in…
NCT00352690 · Washington University School of Medicine, Other · Terminated
Key facts
| NCT number | NCT00352690 |
|---|---|
| Title | A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer |
| Official title | A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | CTI BioPharma Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug, Radiation |
| Interventions | Paclitaxel poliglumex, Carboplatin, External beam radiation therapy |
| Enrollment | 10 |
| Start date | Apr 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Jul 17, 2006 |
| Last update posted | Dec 12, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: